Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention among South African Male Youth

7Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Long-acting pre-exposure prophylaxis (LA-PrEP) formulated as implants and injections are promising prevention method strategies offering simplicity, discretion, and long dose duration. Men are important end users of LA-PrEP, and early assessment of their preferences could enhance downstream male engagement in HIV prevention.Methods: A discrete-choice experiment survey was conducted with 406 men, aged 18-24, in Cape Town, South Africa, to assess preferences for 5 LA-PrEP attributes with 2-4 pictorially-depicted levels: delivery form, duration, insertion location, soreness, and delivery facility. Latent class analysis was used to explore heterogeneity of preferences and estimate preference shares.Results: The median age was 21 (interquartile range 19-22), and 47% were men who have sex with men. Duration was the most important product attribute. Latent class analysis identified 3 classes: "duration-dominant decision makers"(46%) were the largest class, defined by significant preference for a longer duration product. "Comprehensive decision makers"(36%) had preferences shaped equally by multiple attributes and preferred implants. "Injection-dominant decision makers"(18%) had strong preference for injections (vs. implant) and were significantly more likely to be men who have sex with men. When estimating shares for a 2-month injection in the buttocks with mild soreness (HPTN regimen) vs. a 6-month implant (to arm) with moderate soreness (current target), 95% of "injection-dominant decision makers"would choose injections, whereas 79% and 63% of "duration-dominant decision makers"and "comprehensive decision makers"would choose implant.Conclusions: Young South African men indicated acceptability for LA-PrEP. Preferences were shaped mainly by duration, suggesting a sizeable market for implants, and underscoring the importance of product choice. Further research into men's acceptability of LA PrEP strategies to achieve engagement in these HIV prevention tools constitutes a priority.

Cite

CITATION STYLE

APA

Montgomery, E. T., Browne, E. N., Atujuna, M., Boeri, M., Mansfield, C., Sindelo, S., … Minnis, A. M. (2021). Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention among South African Male Youth. Journal of Acquired Immune Deficiency Syndromes, 87(3), 928–936. https://doi.org/10.1097/QAI.0000000000002670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free